Association Between Discharge Medications and Oncologic Post‐Embolization‐Syndrome‐Related Outcomes
Prescribing opioids, along with antiemetics and steroids, at discharge may reduce the likelihood of post-procedural events, such as drug escalation and readmission, in patients undergoing trans-arterial chemoembolization and radioembolization for hepatocellular carcinoma. These findings highlight the importance of a comprehensive pain management strategy in interventional oncology and warrant consideration in clinical practice guidelines.
Authors
- Janice Newsome (ORCID: https://orcid.org/0000-0002-2472-3815)
- S. Benenati
- Menelaos Konstantinidis (ORCID: https://orcid.org/0000-0002-5074-9023)
- Deepak Iyer (ORCID: https://orcid.org/0000-0002-4446-0012)
- John T. Moon (ORCID: https://orcid.org/0000-0003-3110-9060)
- Michal Horný (ORCID: https://orcid.org/0000-0003-3624-6398)
- Judy Wawira Gichoya (ORCID: https://orcid.org/0000-0002-1097-316X)
- Zachary Bercu (ORCID: https://orcid.org/0000-0003-1307-3770)
- Nicholas J Lima (ORCID: https://orcid.org/0009-0002-1837-6201)
- Hanzhou Li (ORCID: https://orcid.org/0000-0003-1614-5717)
- Nathan Sim (ORCID: https://orcid.org/0009-0009-0118-9769)
Institutions
- Dartmouth College (US)
- Brigham and Women's Hospital (US)
- Emory Healthcare (US)
- Harvard University (US)
- Emory University (US)
- Emory and Henry College (US)
- University of Toronto (CA)
- University of Massachusetts Amherst (US)
- Emory Clinic (US)
- Institute for Work & Health (CA)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/cam4.71418
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Harvey L. Neiman Health Policy Institute